The Manufacturers Life Insurance Company Buys 78,278 Shares of Exponent, Inc. (NASDAQ:EXPO)

The Manufacturers Life Insurance Company boosted its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 30.8% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 332,058 shares of the business services provider’s stock after purchasing an additional 78,278 shares during the period. The Manufacturers Life Insurance Company’s holdings in Exponent were worth $23,919,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently bought and sold shares of EXPO. Kayne Anderson Rudnick Investment Management LLC grew its position in Exponent by 336.8% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,329,980 shares of the business services provider’s stock valued at $107,166,000 after buying an additional 1,025,485 shares during the period. Conestoga Capital Advisors LLC boosted its position in Exponent by 6.0% during the second quarter. Conestoga Capital Advisors LLC now owns 1,807,230 shares of the business services provider’s stock worth $146,259,000 after purchasing an additional 102,293 shares during the period. Raymond James & Associates boosted its position in Exponent by 192.8% during the second quarter. Raymond James & Associates now owns 153,171 shares of the business services provider’s stock worth $12,396,000 after purchasing an additional 100,851 shares during the period. Nordea Investment Management AB boosted its position in Exponent by 101.3% during the second quarter. Nordea Investment Management AB now owns 197,660 shares of the business services provider’s stock worth $15,750,000 after purchasing an additional 99,469 shares during the period. Finally, Copeland Capital Management LLC boosted its position in Exponent by 25.6% during the second quarter. Copeland Capital Management LLC now owns 412,853 shares of the business services provider’s stock worth $33,412,000 after purchasing an additional 84,200 shares during the period. Institutional investors own 89.68% of the company’s stock.

Shares of EXPO opened at $82.25 on Friday. The firm’s 50 day simple moving average is $74.73 and its 200 day simple moving average is $76.30. The company has a market capitalization of $4.25 billion, a P/E ratio of 54.83 and a beta of 0.19. Exponent, Inc. has a 1-year low of $58.03 and a 1-year high of $84.96.

Exponent (NASDAQ:EXPO) last announced its earnings results on Thursday, October 29th. The business services provider reported $0.34 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.07. The business had revenue of $98.70 million for the quarter, compared to the consensus estimate of $91.73 million. Exponent had a net margin of 19.63% and a return on equity of 23.66%. Exponent’s quarterly revenue was down 2.8% on a year-over-year basis. During the same period last year, the firm posted $0.36 earnings per share. As a group, research analysts anticipate that Exponent, Inc. will post 1.42 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, December 18th. Investors of record on Friday, December 4th will be paid a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.92%. The ex-dividend date of this dividend is Thursday, December 3rd. Exponent’s dividend payout ratio is currently 49.67%.

In other Exponent news, VP Richard Reiss sold 3,209 shares of Exponent stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $82.50, for a total transaction of $264,742.50. Following the transaction, the vice president now directly owns 5,798 shares of the company’s stock, valued at $478,335. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Maureen T. F. Reitman sold 5,000 shares of Exponent stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $79.13, for a total transaction of $395,650.00. Following the transaction, the vice president now directly owns 33,567 shares in the company, valued at $2,656,156.71. The disclosure for this sale can be found here. Insiders sold 154,955 shares of company stock worth $12,833,163 over the last ninety days. 2.20% of the stock is currently owned by insiders.

A number of brokerages have weighed in on EXPO. BidaskClub upgraded shares of Exponent from a “strong sell” rating to a “sell” rating in a research report on Wednesday, October 28th. William Blair reissued a “market perform” rating on shares of Exponent in a report on Monday, November 2nd. Two analysts have rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the stock. Exponent has an average rating of “Hold” and a consensus target price of $88.67.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.

Further Reading: What is Compound Annual Growth Rate (CAGR)?

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.